Viemed Healthcare Stock Target Price and Analyst Consensus
| VMD Stock | USD 7.57 0.14 1.82% |
The current analyst and expert consensus on Viemed Healthcare is Strong Buy, with 3 strong buy opinions. The current projected Viemed Healthcare target price consensus is 12.27 with 3 analyst opinions. Check out Macroaxis Advice on Viemed Healthcare to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.The most common way Viemed Healthcare analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Viemed Healthcare executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Viemed Healthcare. We encourage you to use your own analysis of Viemed Healthcare to validate this buy or sell advice. Viemed Healthcare buy-or-sell recommendation module provides average expert sentiment on the projected Viemed Healthcare target price to derive its highest and lowest estimates based on projected price volatility of 1.8227.
Lowest Forecast 11.16 | Highest Forecast 13.62 | Target Price 12.27 |
Viemed |
It's important to approach Viemed Healthcare's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Viemed Healthcare Target Price Consensus
Viemed target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Viemed Healthcare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Viemed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Viemed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Viemed Healthcare, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationViemed Healthcare Target Price Projection
Viemed Healthcare's current and average target prices are 7.57 and 12.27, respectively. The current price of Viemed Healthcare is the price at which Viemed Healthcare is currently trading. On the other hand, Viemed Healthcare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Viemed Healthcare Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Viemed Healthcare Target Price
Viemed Healthcare Analyst Ratings
Viemed Healthcare's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Viemed Healthcare stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Viemed Healthcare's financials, market performance, and future outlook by experienced professionals. Viemed Healthcare's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Viemed Healthcare price targets
Viemed Healthcare's stock target price is an estimate of its future price, usually made by analysts. Using Viemed Healthcare's target price to determine if it is a suitable investment can be done through the following steps:- Look at Viemed Healthcare's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Viemed Healthcare's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Viemed Healthcare Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Viemed Healthcare is a key component of Viemed Healthcare valuation and have some predictive power on the future returns of a Viemed Healthcare.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Momentum Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Blockchain Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Viemed Healthcare to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Please note, the presentation of Viemed Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Viemed Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Viemed Healthcare's management manipulating its earnings.